Skip to main content

FDA approves Mylan chemoprotective agent

11/28/2011

PITTSBURGH — The Food and Drug Administration has approved a generic drug made by Mylan for cancer patients.


Mylan announced Monday the approval of dexrazoxane for injection, a generic version of Pharmacia & Upjohn's Zinecard. The drug is a chemoprotective agent, used to protect healthy tissue from cancer drugs.


Various versions of the drug had sales of $3.4 million during the 12-month period ended in September, according to IMS Health.


 


 




Interested in this topic? Sign up for our weekly Retail Health Provider e-newsletter.

X
This ad will auto-close in 10 seconds